Britannia Pharmaceuticals Articles
Ipsen sells North American rights for Apokyn to Britannia Pharma
3 November 2011
Britannia introduces new pre-filled syringe
17 January 2005
Britannia and airPharma sign accord
15 November 2004
Bartek's Apokyn cleared by FDA
24 May 2004
Britannia and Novartis collaborate on DHE migraine treatment
29 September 2003
Britannia plans nasal drug for impotence
10 June 2002
Britannia says Pumactant has promise in asthma
27 May 2002
BRITANNIA LAUNCH SURFACTANT
30 May 1994
Showing 1-10 of 10 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
